Demant As Adr Stock Market Capitalization
| WILYY Stock | USD 18.86 0.03 0.16% |
Demant AS ADR fundamentals help investors to digest information that contributes to Demant AS's financial success or failures. It also enables traders to predict the movement of Demant Pink Sheet. The fundamental analysis module provides a way to measure Demant AS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Demant AS pink sheet.
Demant |
Demant AS ADR Company Market Capitalization Analysis
Demant AS's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Demant AS Market Capitalization | 7.02 B |
Most of Demant AS's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Demant AS ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Demant AS ADR is about 7.02 B. This is 45.78% lower than that of the Healthcare sector and 36.58% lower than that of the Medical Devices industry. The market capitalization for all United States stocks is 63.12% higher than that of the company.
Demant Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Demant AS's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Demant AS could also be used in its relative valuation, which is a method of valuing Demant AS by comparing valuation metrics of similar companies.Demant AS is currently under evaluation in market capitalization category among its peers.
Demant Fundamentals
| Return On Equity | 0.28 | |||
| Return On Asset | 0.071 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 8.18 B | |||
| Shares Outstanding | 446.37 M | |||
| Price To Earning | 36.83 X | |||
| Price To Book | 5.38 X | |||
| Price To Sales | 0.34 X | |||
| Revenue | 19.7 B | |||
| Gross Profit | 14.67 B | |||
| EBITDA | 4.3 B | |||
| Net Income | 2.08 B | |||
| Cash And Equivalents | 1.24 B | |||
| Cash Per Share | 2.73 X | |||
| Total Debt | 6.1 B | |||
| Debt To Equity | 1.64 % | |||
| Current Ratio | 0.78 X | |||
| Book Value Per Share | 19.18 X | |||
| Cash Flow From Operations | 2.62 B | |||
| Earnings Per Share | 0.73 X | |||
| Price To Earnings To Growth | 1.72 X | |||
| Number Of Employees | 20.57 K | |||
| Beta | 0.93 | |||
| Market Capitalization | 7.02 B | |||
| Total Asset | 29.86 B | |||
| Retained Earnings | 6.51 B | |||
| Working Capital | (503 M) | |||
| Current Asset | 5.06 B | |||
| Current Liabilities | 5.56 B | |||
| Z Score | 0.6 | |||
| Net Asset | 29.86 B |
About Demant AS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Demant AS ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Demant AS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Demant AS ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Demant Pink Sheet Analysis
When running Demant AS's price analysis, check to measure Demant AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Demant AS is operating at the current time. Most of Demant AS's value examination focuses on studying past and present price action to predict the probability of Demant AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Demant AS's price. Additionally, you may evaluate how the addition of Demant AS to your portfolios can decrease your overall portfolio volatility.